Toronto Star15d
Titan Mining Announces Phase III Metallurgy Results and Outlines Plans for Natural Flake Graphite Processing Facility in New York State
VANCOUVER, British Columbia, Jan. 16, 2025 (GLOBE NEWSWIRE) — Titan Mining Corporation (TSX: TI) (“Titan” or the “Company”) is pleased to announce the Phase III metallurgy results ...
manilatimes15d
Metagenomi Highlights Progress Across Therapeutic Portfolio and Outlines Anticipated Milestones
EMERYVILLE, Calif., Jan. 16, 2025 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its ...
Financial Post15d
Titan Mining Announces Phase III Metallurgy Results and Outlines Plans for Natural Flake Graphite Processing Facility in New York State
You can save this article by registering for free here. Or sign-in if you have an account.
Toronto Star16d
NexGold Provides Summary of its Transformative Year and Outlines Key Priorities for 2025
TORONTO, Jan. 15, 2025 (GLOBE NEWSWIRE) — NexGold Mining Corp. (TSXV: NEXG; OTCQX: NXGCF) (“NexGold” or the “Company”) is pleased to outline the Company’s key milestones and ...
The Canadian Press16d
NexGold Provides Summary of its Transformative Year and Outlines Key Priorities for 2025
TORONTO, Jan. 15, 2025 (GLOBE NEWSWIRE) -- NexGold Mining Corp. (TSXV: NEXG; OTCQX: NXGCF) (“NexGold” or the “Company”) is pleased to outline the Company’s key milestones and achievements from the ...
manilatimes17d
Kymera Therapeutics Outlines Key 2025 Objectives and Strategy to Advance Industry Leading Portfolio of Oral Immunology Programs
Jan. 14, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines with ...
Daily Globe18d
Farmers Union outlines policy priorities for 2025 session
ST. PAUL — Minnesota Farmers Union is preparing to advocate for a strong agriculture budget, affordable healthcare, support for beginning farmers and other priorities during the 2025 Minnesota ...
Morningstar18d
Xenon Outlines Key Corporate Milestone Opportunities for 2025
2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics ...
Morningstar18d
Pharvaris Outlines 2025 Strategic Priorities
2025 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with ...
The Globe and Mail18d
Beam Therapeutics Announces Progress in Hematology and Genetic Disease Franchises and Outlines Key 2025 Anticipated Catalysts
Jan. 13, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced progress across the ...
The Canadian Press18d
Xenon Outlines Key Corporate Milestone Opportunities for 2025
2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for ...